|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 750 9th Street, NW |
Address2 | Suite 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 14267-12
|
||||||||
|
6. House ID# 326350000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Katie Tenoever |
Date | 7/19/2018 9:46:38 AM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 5818/S. 2843 - "Opioid Workforce Act of 2018" - Supported Legislation.
H.R. 5675 - "To amend title XVIII of the Social Security Act to require prescription Drug Plan Sponsors Under the Medicare Program to Establish Drug Management Programs For At Risk Beneficiaries" - Review and monitor legislation.
H.R. 4841 - "Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018" - Review and monitor legislation.
H.R. 5676 - "Stop Excessive Narcotics in our Retirement Communities Protection Act of 2018" - Review and monitor legislation.
H.R. 5684 - "Protecting Seniors From Opioid Abuse Act" - Review and monitor legislation.
H.R. 5699 - "Hospital Opioid Solutions Toolkit (HOST) Act" - Review and monitor legislation.
H.R. 5686 - "Medicare Clear Health Options in Care for Enrollees Act of 2018" - Review and monitor legislation.
H.R. 5722 - "Dr. Todd Graham Pain Management Improvement Act of 2018" - Review and monitor legislation.
S. 2852 - "The Pandemic and All Hazards Preparedness Act (PAHPA)" - Monitored and reviewed legislation.
Monitored Congressional Proposals concerning health price transparency.
H.R. 3415 - "Megan Rondini Act" - Monitored and provided comment.
H.R. 4613 - "Ensuring Patient Access to Healthcare Records Act of 2017" - Monitored Legislation.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Jeff |
Cohen |
|
|
|
Steve |
Speil |
|
|
|
Paul |
Kidwell |
|
|
|
Jonathan |
Jagoda |
|
|
|
Kathryn |
Wise |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1156/S.1133 "Patient Access to Higher Quality Health Care Act of 2017" - Oppose efforts to repeal certain provisions relating to the limitation on the Medicare exception to the prohibition on certain physician referrals for hospitals and to transparency reports and reporting of physician ownership or investment interests.
Bad Debt Payments to Hospitals - Lawmakers have proposed lowering the amount of Medicare Bad Debt payments to hospitals for Medicare beneficiaries who fail to pay their cost-sharing obligations for treatments provided by the hospital. Oppose any effort to lower such payments.
Oppose any additional site neutral cuts.
Support access to affordable prescription drugs.
Market Stabilization - Support efforts to fund Cost Sharing Reductions.
S. 2051 - "Medicare Care Coordination Improvement Act of 2017" - Monitored Legislation.
Provided input and comment on House Ways and Means Red Tape Initiative.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Jeff |
Cohen |
|
|
|
Steve |
Speil |
|
|
|
Paul |
Kidwell |
|
|
|
Jonathan |
Jagoda |
|
|
|
Kathryn |
Wise |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code COM
16. Specific lobbying issues
FCC Rural Broadband Parity - Support investor-owned access to grants under the FCC for rural broadband.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charles |
Kahn |
|
|
|
Jeff |
Cohen |
|
|
|
Steve |
Speil |
|
|
|
Paul |
Kidwell |
|
|
|
Jonathan |
Jagoda |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |